GCG and type 2 diabetes mellitus: Liraglutide is a licensed type 2 diabetes drug, GLP-1 (glucagon-like peptide 1) analogue, due to its antioxidative and anti-inflammatory properties against TNF-α-induced injury and NF-kB signaling in ECs, and also possesses cardiovascular protection properties [67].